StreetInsider.com News Articles

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

BENGALURU, India & CAMBRIDGE, England--(BUSINESS WIRE)-- Cambridge Cognition Holdings plc ("Cambridge Cognition") (AIM: COG), the neuroscience technology company specialising in digital cognitive assessments, and Ivory, a venture-backed brain health company headquartered in India, announce an agreement for the commercialisation of CANTAB Pathway™ across the healthcare and consumer health markets in India.

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India

Tue, 17 Feb 2026 12:13:00 -0500

Highlights

Ivory will deploy CANTAB Pathway™ across both professional healthcare and consumer health segments in India
Of India’s population of approximately 1.47 billion, estimates indicate that 138 million people are aged over 60, and as many as 34 million may be living with mild or major cognitive impairment
India’s

BofA favors defense and value in the oil and gas sector

Tue, 29 Apr 2025 11:37:54 -0500

Investing.com -- Bank of America told investors it prefers a defensive and value-oriented approach to the U.S. oil and gas sector, as the market grapples with twin economic shocks: a trade war and a supply-driven oil price decline.

“Oil markets are on the frontlines of two economic wars,” BofA analysts wrote, citing damaged OPEC+ cohesion and weakening macro conditions.

BofA believes de-escalation is the most likely path forward on both fronts and has shifted its ratings accordingly, upgrading Diamondback (NASDAQ:FANG) Energy to Buy from Neutral and downgrading ConocoPhillips (NYSE:COP) to Neutral from Buy.